GHS 2022 will promote a dynamic and contemporary program that will include a mixture of keynote panel presentations, dedicated sessions, and lively discussions and debate on the challenges that impact global health security.

The 4-day conference will also include a series of workshops, side-events and panels. 

On 1 July, MMV will co-host a side event with the Australian Therapeutic Goods Administration and Shin Poong Pharmaceutical. The event, Development and Delivery of Antimalarial Innovations: an insurance policy for health security, will feature discussions on:

• the vital role of antimalarial medicines in contributing to disease eradication and global health security
• lessons on what must be overcome in deploying innovative antimalarial medicine from the experience with Pyramax
• regulatory support for systems strengthening and product access in the Indo-Pacific region.

Event speakers

• Joan Herbert, Senior Director, Business Development, MMV
• Su Mi Oh, Director, Global Sales Marketing, Shin Poong Pharmaceutical
• Paul Huleatt, Strategic Partnerships and Program Implementation Lead, Indo-Pacific RSP, RSSM, Therapeutic Goods Administration